Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
51 Ergebnisse für "chemotherapeutic" unter Somagenetix
Stereological analysis of hippocampus in rat treated with chemother...
... chemotherapeutic agent oxaliplatin. Folia Morphologica, 80(1):26-32. Copy Abstract Background: Oxaliplatin (OX) has ... Stereological analysis of hippocampus in rat treated with chemotherapeutic agent oxaliplatin ... Stereological analysis of hippocampus in rat treated with chemotherapeutic agent oxaliplatin ... Stereological analysis of hippocampus in rat treated with chemotherapeutic agent oxaliplatin ...
Methadone - not a magic bullet in melanoma therapy - Zurich Open Re...
... cancer cell lines to chemotherapeutic agents has promoted the hypothesis that Met may be a useful ... chemotherapeutic agent, an effect on melanoma cell viability in vitro. Only a small fraction (4.3%) of our 102 ... lines to chemotherapeutic agents has promoted the hypothesis that Met may be a useful adjuvant to cancer ... chemotherapy. We wanted to address whether Met has, alone or in combination with a chemotherapeutic agent, an ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
16 Ergebnisse für "chemotherapeutic" unter University Hospital Zurich, Research and Education Office
Microsoft Word - MSCC ScoreSheed Print2.docx
... , Burchenal JH. The Clinical Evaluation of Chemotherapeutic Agents in Cancer. In: MacLeod CM, ed. Evaluation ... of Chemotherapeutic Agents. New York: Columbia University Press; 1949:196. ECOG Leistungsstatus1 KI ... , Burchenal JH. The Clinical Evaluation of Chemotherapeutic Agents in Cancer. In: MacLeod CM, ed. Evaluation ... of Chemotherapeutic Agents. New York: Columbia University Press; 1949:196. ECOG Leistungsstatus1 KI ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
21 Ergebnisse für "chemotherapeutic" unter University of Zurich
Differential antiproliferative mechanisms of novel derivative of be...
... -dependent chemotherapeutic response marker maspin in HCT 116 and impairment in ribosome biogenesis in SW620 ... possible role as an antimetastatic agent and encourage further in vivo studies on the chemotherapeutic ... detected (e.g., up-regulation of the p53-dependent chemotherapeutic response marker maspin in HCT 116 and ... in vivo studies on the chemotherapeutic potential of this compound against colorectal carcinoma ...
Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer...
... Microtubule-stabilizing agents (MSAs) are efficacious chemotherapeutic drugs widely used for the ... dynamics. Abstract Microtubule-stabilizing agents (MSAs) are efficacious chemotherapeutic drugs widely used ... chemotherapeutic drugs widely used for the treatment of cancer. Despite the importance of MSAs for medical ... chemotherapeutic drugs widely used for the treatment of cancer. Despite the importance of MSAs for medical ...
ETH Zürich - Numerische Materialmodellierung
8005 Zürich, Technoparkstrasse 1 / Einstein PFA G 11 (2. OG)
ETH Zürich - Numerische Materialmodellierung
Technoparkstrasse 1
8005 Zürich
10 Ergebnisse für "chemotherapeutic" unter ETH Zürich - Numerische Materialmodellierung
Next-generation DNA damage sequencing - Research Collection
... ; oxidative stress, chemotherapeutic drugs, environmental pollutants, and sun exposure. Preferred sequences ... evaluate and predict the efficacy of chemotherapeutic drugs. Show more Permanent link More Cited 24 times ... , chemotherapeutic drugs, environmental pollutants, and sun exposure. Preferred sequences for damage formation and ... efficacy of chemotherapeutic drugs. Show more Permanent link https://doi.org/10.3929/ethz-b-000448689 ...
Platinum nanoparticles for selective treatment of liver cancer cell...
... of comments Liver tumours are treated with chemotherapeutic agents that do not specifically target ... chemotherapeutic agents still play an important role in cancer treatment. These include platinum-based cytotoxic ... . 14.02.2019 by Oliver Renn mode_comment Number of comments Liver tumours are treated with chemotherapeutic ... rise. However, conventional chemotherapeutic agents still play an important role in cancer treatment ...
ETH Zürich - Feasibility Lab
Technoparkstrasse 1
8005 Zürich
10 Ergebnisse für "chemotherapeutic" unter ETH Zürich - Feasibility Lab
Platinum nanoparticles for selective treatment of liver cancer cell...
... mode_comment Number of comments Liver tumours are treated with chemotherapeutic agents that do not ... chemotherapeutic agents still play an important role in cancer treatment. These include platinum-based cytotoxic ... mode_comment Number of comments Liver tumours are treated with chemotherapeutic agents that do not specifically ... chemotherapeutic agents still play an important role in cancer treatment. These include platinum-based cytotoxic ...
Infozentrum: Catalog
... : From Chemotherapeutic to Hyperthermia-Based Therapy Nanomedicine for Cancer Therapy : From ... Chemotherapeutic to Hyperthermia-Based Therapy Classification Publisher Medium Nanomedicine for Inflammatory ... and Technology : Nanotheranostics Nanomedicine for Cancer Therapy : From Chemotherapeutic to ... Technology : Nanotheranostics Nanomedicine for Cancer Therapy : From Chemotherapeutic to Hyperthermia-Based ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
2 Ergebnisse für "chemotherapeutic" unter ETH Entrepreneurship
Research – Integrative Approaches in Structural Biology | ETH Zurich
... some of the most widely-used chemotherapeutic small molecules, and point mutations in the proteins ... . Microtubules are direct targets of some of the most widely-used chemotherapeutic small molecules, and point ...
Artificial Metastasis: Cancer Cell Migration in Microengineered Env...
... clinical relevance in regards to widely used chemotherapeutic drugs that arrest cells in exactly this phase ... clinical relevance in regards to widely used chemotherapeutic drugs that arrest cells in exactly this phase ...
InSphero AG
8952 Schlieren, Wagistrasse 27
+41 44 515049-0
info@insphero.com
InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.
InSphero AG
Wagistrasse 27
8952 Schlieren
22 Ergebnisse für "chemotherapeutic" unter InSphero AG
NA-DublinCopy-Correct.pdf
... minimize side effects of chemotherapeutic agents +/- radiotherapy new compound screening for improved ... chemotherapeutic compounds. These compounds were tested alone and in combination with an acute 2 Gy radiation ... minimize side effects of chemotherapeutic agents +/- radiotherapy new compound screening for improved ... chemotherapeutic compounds. These compounds were tested alone and in combination with an acute 2 Gy radiation ...
Folie 1
... 10 classical chemotherapeutic compounds. These chemotherapeutics were tested alone and in combination ... /Chemotherapy minimize side effects of chemotherapeutic agents +/- radiotherapy new compound screening for ... 10 classical chemotherapeutic compounds. These chemotherapeutics were tested alone and in combination ... /Chemotherapy minimize side effects of chemotherapeutic agents +/- radiotherapy new compound screening for ...
ANSYS Switzerland GmbH
8005 Zürich, Technoparkstrasse 1 / Zeppelin 3003
+41 44 500 93 60
ANSYS ist der weltweit führende Anbieter von technischen Simulationslösungen und entwickelt, vertreibt und unterstützt Software für Engineering Simulation. Was ANSYS auszeichnet und von anderen professionellen Berechnungsprogrammen abhebt, ist unter anderem seine Multiphysikfähigkeit. Es kann neben Mechanik und Heattransfer ebenso Fluidynamik, Akustik und Elektromagnetik berechnet werden. Auch die gleichzeitige gekoppelte Behandlung dieser physikalischen Aspekte in einer Simulation ist abgedeckt.
ANSYS Switzerland GmbH
Technoparkstrasse 1
8005 Zürich
5 Ergebnisse für "chemotherapeutic" unter ANSYS Switzerland GmbH
Targeting a Tumor | Healthcare | ANSYS Advantage
... increasing the accuracy of delivering a chemotherapeutic drug to a lung tumor to 90 percent, versus 20 ... advance the field of personalized medicine. By increasing the accuracy of delivering a chemotherapeutic ... chemotherapeutic drug to a lung tumor to 90 percent, versus 20 percent by conventional aerosol methods, they have ... advance the field of personalized medicine. By increasing the accuracy of delivering a chemotherapeutic ...
Targeting a Tumor | Healthcare | ANSYS Advantage
... increasing the accuracy of delivering a chemotherapeutic drug to a lung tumor to 90 percent, versus 20 ... advance the field of personalized medicine. By increasing the accuracy of delivering a chemotherapeutic ... chemotherapeutic drug to a lung tumor to 90 percent, versus 20 percent by conventional aerosol methods, they have ... advance the field of personalized medicine. By increasing the accuracy of delivering a chemotherapeutic ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
1 Ergebnisse für "chemotherapeutic" unter Roche Glycart AG
ASH 2020 In-Depth Report: Leukaemia
... chemotherapeutic agents. However, more recently, relatively effective and less intensive AML treatments have become ... chemotherapeutic agents. However, more recently, relatively effective and less intensive AML treatments have become ...
Blutspende SRK Zürich
https://www.blutspendezuerich.ch/
8952 Schlieren, Rütistrasse 19
+41 58 272 52 52
info@zhbsd.ch
The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).
Blutspende SRK Zürich
Rütistrasse 19
8952 Schlieren
1 Ergebnisse für "chemotherapeutic" unter Blutspende SRK Zürich
TMH477262.pdf
... in the G0 phase of the cell cycle [62–64]. However, under the chemotherapeutic stress of the small ... in the G0 phase of the cell cycle [62–64]. However, under the chemotherapeutic stress of the small ...
